NDC 68788-8741-06 - tizanidine
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 68788-8741
- Requested NDC
- 68788-8741-06
- Package NDCs from labels
- 68788-8741-2, 68788-8741-3, 68788-8741-6, 68788-8741-9, 68788-8741-1, 68788-8741-8, 68788-8741-06
- Manufacturer
- Preferred Pharmaceuticals Inc.
- Effective date
- 2026-10-05
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| tizanidine - Preferred Pharmaceuticals Inc. | Preferred Pharmaceuticals Inc. | 2026-10-05 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68788-8741-1 | tizanidine | 100 in 1 BOTTLE | TABLET | 100 | 2 | |
| 68788-8741-2 | tizanidine | 20 in 1 BOTTLE | TABLET | 20 | 2 | |
| 68788-8741-3 | tizanidine | 30 in 1 BOTTLE | TABLET | 30 | 2 | |
| 68788-8741-6 | tizanidine | 60 in 1 BOTTLE | TABLET | 60 | 2 | |
| 68788-8741-8 | tizanidine | 120 in 1 BOTTLE | TABLET | 120 | 2 | |
| 68788-8741-9 | tizanidine | 90 in 1 BOTTLE | TABLET | 90 | 2 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 68788-8741 | TIZANIDINE TABLET [PREFERRED PHARMACEUTICALS INC.] | 1 | Current NDC, 6 package rows | 20240922_f0e4eb26-6733-4df6-bb3c-86bf4d976f42.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 68788-8741-1 | EA - Each | 68788-8741 | 9f072945-e2ca-4c20-ac40-5fa4626b0e17 | 1 | 2024-11-05 |
| 68788-8741-2 | EA - Each | 68788-8741 | 41d958a8-d7bb-407f-8185-d3cd3d1aec20 | 1 | 2024-11-05 |
| 68788-8741-3 | EA - Each | 68788-8741 | 6e20413c-8f24-4339-8e56-7ef7f6f24792 | 1 | 2024-11-05 |
| 68788-8741-6 | EA - Each | 68788-8741 | ee0e57d3-8446-411d-bcdd-ea446ce32db9 | 1 | 2024-12-10 |
| 68788-8741-8 | EA - Each | 68788-8741 | 737a68e3-79ac-4040-8591-b3808ee4099f | 1 | 2024-12-10 |
| 68788-8741-9 | EA - Each | 68788-8741 | 1e59e21d-2953-4c0d-8e3c-c0f53595083c | 1 | 2024-12-10 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| tizanidine hydrochloride | TIZANIDINE HYDROCHLORIDE | Advagen Pharma Limited | 7f39499a-98cf-4d13-9b07-ccb5c22e43c8 | 2026-11-04 | Warnings, Adverse reactions | B53E3NMY5C |
| Tizanidine | TIZANIDINE | American Health Packaging | 3670f9e3-988d-48e6-9df0-d403d699e08a | 2026-10-30 | Warnings, Adverse reactions | B53E3NMY5C |
| Tizanidine | TIZANIDINE | PD-Rx Pharmaceuticals, Inc. | fd16a25c-67b6-ae6c-e053-6394a90aeee0 | 2026-10-28 | Warnings, Adverse reactions | 313412 313413 B53E3NMY5C |
| Tizanidine | TIZANIDINE | PD-Rx Pharmaceuticals, Inc. | fdf4f09d-4537-a438-e053-6394a90a573d | 2026-10-28 | Warnings, Adverse reactions | 313413 B53E3NMY5C |
| Tizanidine | TIZANIDINE | St. Mary's Medical Park Pharmacy | cfd52c0c-a7c2-e23d-e053-2a95a90abbd1 | 2026-10-23 | Warnings, Adverse reactions | 313412 B53E3NMY5C |
| Tizanidine | TIZANIDINE | REMEDYREPACK INC. | 17ca23af-c88f-4235-930a-d7568051696f | 2026-10-15 | Warnings, Adverse reactions | 313413 B53E3NMY5C |
| tizanidine | TIZANIDINE | Cardinal Health 107, LLC | eeb18068-75c8-42d0-a006-1b134648333f | 2026-10-06 | Warnings, Adverse reactions | ANDA076533 313413 B53E3NMY5C |
| TIZANIDINE HYDROCHLORIDE | TIZANIDINE HYDROCHLORIDE | Preferred Pharmaceuticals Inc. | ae9b6808-632f-4204-8581-bf146dcab69f | 2026-10-05 | Warnings, Adverse reactions | B53E3NMY5C |
| TIZANIDINE HYDROCHLORIDE | TIZANIDINE HYDROCHLORIDE | Preferred Pharmaceuticals Inc. | 6439a7ef-1b22-4fa1-9be3-eedd3cd24191 | 2026-10-05 | Warnings, Adverse reactions | B53E3NMY5C |
| Tizanidine | TIZANIDINE | Preferred Pharmaceuticals, Inc. | 32c3be66-5398-425c-ac65-e57ba819bb43 | 2026-10-05 | Warnings, Adverse reactions | 313413 B53E3NMY5C |
| tizanidine | TIZANIDINE | Preferred Pharmaceuticals Inc. | f0e4eb26-6733-4df6-bb3c-86bf4d976f42 | 2026-10-05 | Warnings, Adverse reactions | ANDA076533 68788-8741-8 68788-8741-6 68788-8741-3 68788-8741-9 68788-8741-1 68788-8741-2 68788-8741 68788874106 313413 d490555b-0594-4819-a5de-420f9c1bfe99 f0e4eb26-6733-4df6-bb3c-86bf4d976f42 B53E3NMY5C |
| Tizanidine | TIZANIDINE | Preferred Pharmaceuticals Inc. | 3c993e3c-ee52-45a7-be39-60eaac7a1092 | 2026-10-02 | Warnings, Adverse reactions | 313412 B53E3NMY5C |
| Tizanidine | TIZANIDINE | A-S Medication Solutions | 180985f0-3fbd-4868-a826-b84101618a03 | 2026-10-01 | Warnings, Adverse reactions | 313412 313413 B53E3NMY5C |
| Tizanidine Hydrochloride | TIZANIDINE HYDROCHLORIDE | Apotex Corp. | 3dd09a0d-a782-1d6d-a552-b71e5bcbf2fe | 2026-09-18 | Warnings, Adverse reactions | B53E3NMY5C |
| tizanidine | TIZANIDINE | Apotex Corp. | 01c0d3d3-2373-a1b7-822a-80a66291a248 | 2026-09-18 | Warnings, Adverse reactions | ANDA076533 60505-0252 313412 313413 4bf9e490-aaca-0e56-d17d-9f513e09f552 01c0d3d3-2373-a1b7-822a-80a66291a248 B53E3NMY5C |
| Lymph Tonic II | ECHINACEA (ANGUSTIFOLIA), COLLINSONIA CANADENSIS, PHYTOLACCA DECANDRA, KALI IODATUM, PINUS SYLVESTRIS, PIX LIQUIDA, FERRUM PHOSPHORICUM, AESCULUS HIPPOCASTANUM, BARYTA CARBONICA, BERBERIS VULGARIS, CALCAREA CARBONICA, CALCAREA PHOSPHORICA, CAUSTICUM, HEPAR SULPHURIS CALCAREUM, KREOSOTUM, LYCOPODIUM CLAVATUM, MERCURIUS SOLUBILIS, NATRUM MURIATICUM, NITRICUM ACIDUM, PHOSPHORUS, PULSATILLA (PRATENSIS), SILICEA, STELLARIA MEDIA, SULPHUR, TEREBINTHINA, THUJA OCCIDENTALIS, BUFO RANA | BioActive Nutritional, Inc. | 0e3265b0-b210-4a4c-80d2-8a9712981d4e | 2026-09-17 | Warnings | ETJ7Z6XBU4 |
| tizanidine hydrochloride | TIZANIDINE HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | e19f83b8-8c59-415c-a744-7473d46ab0ca | 2026-09-16 | Warnings, Adverse reactions | B53E3NMY5C |
| tizanidine hydrochloride | TIZANIDINE HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | e94aa8b1-74ed-46b7-94c5-53d5d5630be6 | 2026-09-16 | Warnings, Adverse reactions | B53E3NMY5C |
| tizanidine hydrochloride | TIZANIDINE HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | d7d5dce0-f8a2-404d-9e87-e2235f5d3268 | 2026-09-16 | Warnings, Adverse reactions | B53E3NMY5C |
| Psoriasis Control | CENTELLA ASIATICA, SODIUM CHLORIDE, AND SILICON DIOXIDE | Forces of Nature | 2db33771-0bb9-49f8-84fa-dddc28e4ba26 | 2026-09-04 | Warnings | ETJ7Z6XBU4 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.